Cart
sales@molnova.com
Home - Products - GPCR/G Protein - Glucagon Receptor - Retatrutide

Retatrutide

Retatrutide

Catalog No. M36652

Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide can be used to study obesity.

Size Price / USD Stock Quantity
2MG 375 Get Quote
5MG 591 Get Quote
10MG 947 Get Quote
25MG 1352 Get Quote
50MG 1831 Get Quote
100MG 2421 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Retatrutide
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Tamer Coskun, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022 Sep 6;34(9):1234-1247.e9.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • CCG-143140

    CCG-143140 is a GLP-1 receptor inverse agonists.

  • HAEGTFT

    HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.

  • (S, R)-LSN 3318839

    (S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.

Sign In Join Free